オオバヤシ シゲル   OBAYASHI Shigeru
  大林 茂
   所属   埼玉医科大学  医学部 総合医療センター リハビリテーション科
   職種   教授
論文種別 学術雑誌(原著)
言語種別 英語
査読の有無 査読あり
表題 Synthesis and evaluation of 3-(4-chlorobenzyl)-8-[11C]methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one: a PET tracer for imaging sigma(1) receptors.
掲載誌名 正式名:Nuclear medicine and biology
ISSNコード:09698051
出版社 ELSEVIER SCIENCE INC
巻・号・頁 29(4),469-76頁
著者・共著者 Ming-Rong Zhang,Terushi Haradahira,Jun Maeda,Takashi Okauchi,Kouichi Kawabe,Takayo Kida,Shigeru Obayashi,Kazutoshi Suzuki,Tetsuya Suhara
発行年月 2002/05
概要 3-(4-Chlorobenzyl)-8-methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one (1), a putative dopamine D(4) receptor antagonist (k(i) = 8.7 nM), was labeled by positron-emitter (11C) and its pharmacological evaluation was carried out with in vitro quantitative autoradiography and positron emission tomography (PET). 11C-Methylation of a corresponding desmethyl precursor (2) with [11C]CH(3)I gave [11C]1 with>or=98% of radiochemical purity after HPLC purification and 67-90 GBq/micromol of specific activity at the end of synthesis. The in vitro autoradiography using rat brain sections demonstrated that [11C]1 shows no specific binding to the D(4) receptors, but a high specific binding to sigma(1) receptors (IC(50) = 105 nM). In the PET study with monkey brain, [11C]1 was highly taken up by the brain andtrapped in the brain for at least 90 min. The distribution pattern of radioactivity in the brain was striatum>thalamus>frontal cortex>cerebellum, which was same as the result of in vitro autoradiography. Pre-treatment with non-radioactive 1 (1 mg/kg) produced a significant reduction of radioactivity in all the regions including the cerebellum. Pre-treatment with (+)pentazocine (1 m
DOI 10.1016/S0969-8051(02)00293-7
PMID 12031882